---
title: "Pre-market hot trades in US stocks: Marvell Tech pre-market up 22.15%; Hitek Global Inc. pre-market down 20.06%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288387970.md"
description: "Marvell Tech pre-market rose 22.15%; Hitek Global Inc. pre-market fell 20.06%; VisionSys AI pre-market rose 143.46%; Decent pre-market rose 120.62%; Sunshine Biopharma pre-market rose 57.21%"
datetime: "2026-06-02T08:17:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288387970.md)
  - [en](https://longbridge.com/en/news/288387970.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288387970.md)
---

# Pre-market hot trades in US stocks: Marvell Tech pre-market up 22.15%; Hitek Global Inc. pre-market down 20.06%

**Pre-market Hot Trades in US Stocks**

Marvell Technology is up 22.15% in pre-market trading, based on recent key news:

1.  On June 2, Marvell Technology launched the Teralynx T100 switch, supporting data transmission of 102.4Tb per second, designed for AI models and cloud data centers, driving the stock price up. Source: Zhitong Finance
    
2.  On June 2, NVIDIA CEO Jensen Huang referred to Marvell as the "next trillion-dollar company" at COMPUTEX, emphasizing the collaboration between the two in the optical field, boosting market confidence. Source: Wall Street Insight
    
3.  On June 1, analysts raised Marvell's target price to $240-300 due to strong demand for its AI data centers, driving the stock price up. Source: Jinshi Data AI demand drives data center growth, optical technology in focus.
    

Hitek Global Inc. is down 20.06% in pre-market trading, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

**Top Gainers in Pre-market US Stocks**

VisionSys AI is up 143.46% in pre-market trading, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Decent is up 120.62% in pre-market trading, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Sunshine Biopharma is up 57.21% in pre-market trading, based on recent key news:

1.  On June 1, Sunshine Biopharma received approval from Canada to produce the generic drug rivaroxaban tablets. This approval allows the company to launch the product through its Canadian subsidiary Nora Pharma's distribution network in October 2026, significantly boosting the stock price.
    
2.  On May 29, the company released relevant information through the EDGAR system, emphasizing its drug development activities and future growth expectations. This information enhanced market confidence in the company's future performance, further driving the stock price up. Recent favorable policies in the pharmaceutical industry have led to significant capital inflow

### Related Stocks

- [MRVL.US](https://longbridge.com/en/quote/MRVL.US.md)
- [HKIT.US](https://longbridge.com/en/quote/HKIT.US.md)
- [VSA.US](https://longbridge.com/en/quote/VSA.US.md)
- [DXST.US](https://longbridge.com/en/quote/DXST.US.md)
- [SBFM.US](https://longbridge.com/en/quote/SBFM.US.md)

## Related News & Research

- [Marvell shares jump after chipmaker wins spot in S&P 500](https://longbridge.com/en/news/289050820.md)
- [Why Marvell Technology Rallied in May](https://longbridge.com/en/news/288960169.md)
- [Forget AI Models. This Company Sells What Every AI Giant Needs.](https://longbridge.com/en/news/289086501.md)
- [These 3 Smart AI ETFs Unlock the Trillion-Dollar Tech Boom Without the Single-Stock Gamble](https://longbridge.com/en/news/289042536.md)
- [Tempus AI (TEM) Valuation Check As FDA Approval And New AI Tools Shape Growth Expectations](https://longbridge.com/en/news/289302838.md)